Diversity Alliance for Science will hold its Fourth Annual Networking Conference and Expo on May 17?18, 2011, in Newark, New Jersey,
Diversity Alliance for Science will hold its Fourth Annual Networking Conference and Expo on May 17–18, 2011, in Newark, New Jersey. The two-day event will showcase senior government officials, pharmaceutical executives, and CEOs of scientific and clinical businesses, and feature personal networking, relationship building, and collaboration opportunities.
Diversity Alliance for Science supports, mentors, and develops minority-, women-, disabled-, small disadvantaged-, HUBZone-, veteran/service-disabled-, and LGBT-owned businesses in the life science industry. It also works to build relationships between these businesses and government agencies, pharmaceutical firms, biotech companies, and academic medical centers. The primary focus of Diversity Alliance for Science is to identify, develop, and increase spending with diverse suppliers in the life science industry.
This year’s Conference is supported by GlaxoSmithKline, Merck, Amgen, Pfizer, ExecuPharm, Fisher Scientific, Guard Dog Brand Development, Henry Schein, Inc., Johnson & Johnson, Sanofi-aventis, Novartis, Eli Lilly and Company, Abbott, Genentech, VWR International, Daiichi-Sankyo, The Takeda Oncology Company, ISM Pharmaceutical Forum, Bogier Clinical & IT Solutions, Inc., A10 Clinical Solutions, Inc., Liberty IRB, Inc., Bright Pharmaceutical Services, Research Assist, Inc., Integrated Resources, Inc., US Tech Solutions, Drug Safety Alliance, Inc., Caligor Rx, Ancillare Global Clinical Strategies, Spectraforce, and East Hill Video.
Best of the Week: EAS Conference Coverage, IR Spectroscopy, Microplastics
November 22nd 2024Top articles published this week include highlights from the Eastern Analytical Symposium, a news article about the infrared (IR) spectroscopy market, and a couple of news articles recapping spectroscopic analysis of microplastics.
FT-IR Analysis of pH and Xylitol Driven Conformational Changes of Ovalbumin–Amide VI Band Study
November 21st 2024This study uses Fourier transform infrared (FT-IR) spectroscopy to analyze how the globular protein ovalbumin's secondary structures transition under varying pH conditions in the presence of the cosolvent xylitol, highlighting the role of noncovalent interactions in these conformational changes.